Penumbra (PEN) Tax Rate Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,134.00 |
| Dec 31, 2025 | 164.00 |
| Sep 30, 2025 | -1,347.00 |
| Jun 30, 2025 | -2,264.00 |
| Mar 31, 2025 | -1,413.00 |
| Dec 31, 2024 | 6,612.00 |
| Sep 30, 2024 | -492.00 |
| Jun 30, 2024 | 1,978.00 |
| Mar 31, 2024 | 2,346.00 |
| Dec 31, 2023 | -8,770.00 |
| Sep 30, 2023 | -14,401.00 |
| Jun 30, 2023 | 21,889.00 |
| Mar 31, 2023 | -10,039.00 |
| Dec 31, 2022 | 576.00 |
| Sep 30, 2022 | 17,803.00 |
| Jun 30, 2022 | -23,460.00 |
| Mar 31, 2022 | 8,919.00 |
| Dec 31, 2021 | -57,522.00 |
| Sep 30, 2021 | -5,315.00 |
| Jun 30, 2021 | -558.00 |
| Mar 31, 2021 | -20,667.00 |
| Dec 31, 2020 | 59,423.00 |
| Sep 30, 2020 | 3,480.00 |
| Jun 30, 2020 | 4,448.00 |
| Mar 31, 2020 | 20,682.00 |
| Dec 31, 2019 | 879.00 |
| Sep 30, 2019 | 2,317.00 |
| Jun 30, 2019 | 3,097.00 |
| Mar 31, 2019 | 5,525.00 |
| Dec 31, 2018 | 16,319.00 |
| Sep 30, 2018 | -4,483.00 |
| Jun 30, 2018 | 130.00 |
| Mar 31, 2018 | 3,436.00 |
| Dec 31, 2017 | -9,300.00 |
| Sep 30, 2017 | -115,349.00 |
| Jun 30, 2017 | -93,919.00 |
| Mar 31, 2017 | -6,937.00 |
| Dec 31, 2016 | -7,110.00 |
| Sep 30, 2016 | 113,353.00 |
| Jun 30, 2016 | 85,061.00 |
| Mar 31, 2016 | -4,903.00 |
| Dec 31, 2015 | 1,271.00 |
| Sep 30, 2015 | -13.00 |